Zevra Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Zevra Therapeutics, Inc. (ZVRA) reported Increase (Decrease) in Other Noncurrent Assets of -$45.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-05
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2024-12-31 was $0.00.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2023-12-31 was -$88.00K.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2016-09-30 was $361.00K.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was -$451.00K.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was $5.00K.
- Zevra Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was -$386.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$45.00K 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | -$451.00K 10-K · filed 2026-03-09 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 10-K · filed 2026-03-09 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 | |||
| 2023-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $5.00K 10-K · filed 2025-03-12 | ||
| 2023-09-30 | $93.00K 10-Q · filed 2024-11-13 | |||
| 2022-12-31 | -$386.00K 10-K · filed 2024-04-01 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-07 | |||
| 2016-09-30 | $361.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $363.00K 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | $2.00K 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |